drugset / Trial / NCT05038098

Magnetic Sentinel Lymph Node Mapping in Gastric Cancer

NCT05038098

Phase 1 Not yet recruiting 20 enrolled M.D. Anderson Cancer Center
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

This phase I finds out the possible benefits and/or side effects of using magnetic tracer FerroTrace and the fluorescent dye indocyanine green to identify the lymph nodes that cancer is most likely to have spread to in patients with gastric cancer that are undergoing gastrectomy. Using FerroTrace in combination with the indocyanine green dye may help researchers better detect the disease.

Timeline

Start
2026-03-31
Primary completion
2027-02-02
Completion
2027-02-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent Other